NZ560415A - Systems and method for identifying replikin scaffolds and uses of said replikin scaffolds - Google Patents

Systems and method for identifying replikin scaffolds and uses of said replikin scaffolds

Info

Publication number
NZ560415A
NZ560415A NZ560415A NZ56041506A NZ560415A NZ 560415 A NZ560415 A NZ 560415A NZ 560415 A NZ560415 A NZ 560415A NZ 56041506 A NZ56041506 A NZ 56041506A NZ 560415 A NZ560415 A NZ 560415A
Authority
NZ
New Zealand
Prior art keywords
replikin
virus
peptide
lysine
seq
Prior art date
Application number
NZ560415A
Other languages
English (en)
Inventor
Samuel Bogoch
Elenore S Bogoch
Samuel Winston Bogoch
Anne-Elenore Bogoch Borsanyi
Original Assignee
Samuel Bogoch
Elenore S Bogoch
Samuel Winston Bogoch
Anne Elenore Bogoch Borsanyi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/014443 external-priority patent/WO2005104754A2/en
Application filed by Samuel Bogoch, Elenore S Bogoch, Samuel Winston Bogoch, Anne Elenore Bogoch Borsanyi filed Critical Samuel Bogoch
Priority to NZ584367A priority Critical patent/NZ584367A/en
Priority to NZ593774A priority patent/NZ593774A/xx
Publication of NZ560415A publication Critical patent/NZ560415A/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
NZ560415A 2005-02-16 2006-02-16 Systems and method for identifying replikin scaffolds and uses of said replikin scaffolds NZ560415A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NZ584367A NZ584367A (en) 2005-02-16 2006-02-16 Systems and methods for indentifying Replikin scaffolds and uses of said Replikin scaffolds
NZ593774A NZ593774A (en) 2005-02-16 2006-02-16 Systems and methods for identifying Replikin scaffolds and uses of said Replikin scaffolds

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65308305P 2005-02-16 2005-02-16
PCT/US2005/014443 WO2005104754A2 (en) 2004-04-28 2005-04-28 System and method for identifying complex patterns of amino acids
PCT/US2006/005343 WO2006088962A2 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof

Publications (1)

Publication Number Publication Date
NZ560415A true NZ560415A (en) 2010-05-28

Family

ID=36917023

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ560415A NZ560415A (en) 2005-02-16 2006-02-16 Systems and method for identifying replikin scaffolds and uses of said replikin scaffolds

Country Status (8)

Country Link
EP (1) EP1859063A4 (https=)
JP (1) JP2008539164A (https=)
AU (1) AU2006214332B2 (https=)
CA (1) CA2598381A1 (https=)
IL (1) IL185308A0 (https=)
NZ (1) NZ560415A (https=)
SG (1) SG160327A1 (https=)
WO (1) WO2006088962A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
KR20090016671A (ko) * 2006-05-30 2009-02-17 사무엘 보고치 레플리킨 펩티드 및 이의 용도
US8050871B2 (en) 2006-10-24 2011-11-01 Samuel Bogoch Method of predicting influenza outbreaks by correlating an increase in replikin count in shrimp white spot syndrome virus and/or taura syndrome virus
US20090017052A1 (en) * 2007-01-18 2009-01-15 Samuel Bogoch Methods of determining lethality of pathogens and malignancies involving replikin peak genes
JP5675348B2 (ja) * 2007-05-30 2015-02-25 ボゴーク，サミュエル 水産養殖における無脊椎動物の病原性感染に対する合成レプリキンペプチド
EP2300493A2 (en) * 2008-04-23 2011-03-30 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
SG193783A1 (en) * 2008-08-08 2013-10-30 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
SG175275A1 (en) * 2009-04-23 2011-11-28 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
WO2013013075A2 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
US20130243803A1 (en) 2012-03-09 2013-09-19 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0221748A3 (en) 1985-11-01 1988-10-12 Samuel Dr. Bogoch A process for the production of human antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6242578B1 (en) 1994-02-17 2001-06-05 Samuel Bogoch Aglyco products and methods of use
US7420028B2 (en) * 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7442761B2 (en) * 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US11620305B2 (en) 2021-03-25 2023-04-04 Salesforce.Com, Inc Ruleset engine for generating homogeneous data sets

Also Published As

Publication number Publication date
WO2006088962A2 (en) 2006-08-24
WO2006088962A3 (en) 2008-01-24
EP1859063A4 (en) 2012-02-01
CA2598381A1 (en) 2006-08-24
AU2006214332A1 (en) 2006-08-24
WO2006088962A9 (en) 2006-11-16
SG160327A1 (en) 2010-04-29
IL185308A0 (en) 2008-02-09
EP1859063A2 (en) 2007-11-28
JP2008539164A (ja) 2008-11-13
AU2006214332B2 (en) 2012-03-22

Similar Documents

Publication Publication Date Title
US7894999B2 (en) Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
AU2010200602B2 (en) Replikin peptides and uses thereof
AU2002309514B2 (en) Replikin peptides and uses thereof
US9388234B2 (en) Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
US20070053916A1 (en) Replikin peptides in rapid replication of glioma cells and in influenza epidemics
Waqas et al. Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope‐Based Peptide Vaccine and Novel Compounds against Novel SARS‐CoV‐2 through Virtual Screening
NZ560415A (en) Systems and method for identifying replikin scaffolds and uses of said replikin scaffolds
Fahimi et al. Dengue virus type-3 envelope protein domain III; expression and immunogenicity
NZ573079A (en) Replikin peptides and uses thereof
JP2006500001A (ja) レプリキンペプチドとその使用
NZ528819A (en) Identification and use of replikin peptides in influenza viruses
Choy et al. Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development
US9254315B2 (en) Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
NZ584367A (en) Systems and methods for indentifying Replikin scaffolds and uses of said Replikin scaffolds
Zhang et al. Exploration of the BF2* 15 major histocompatibility complex class I binding motif and identification of cytotoxic T lymphocyte epitopes from the H5N1 influenza virus nucleoprotein in chickens
Bibi et al. Vaccinomics-driven proteome-wide screening of Haemophilus influenzae for the prediction of common putative vaccine candidates
Padmanabhan et al. Structural Characterization of a Unique Peptide in Porin: An Approach Towards Specific Detection of Salmonella enterica Serovar Typhi
IL158109A (en) Replikin peptides and uses thereof
AU2013201657A1 (en) Replikin peptides and uses thereof
JP2009100769A (ja) レプリキンペプチドとその使用

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 16 FEB 2016 BY CPA GLOBAL

Effective date: 20130216

LAPS Patent lapsed